Defer of the the General Shareholders’ Meeting of August 16, 2019


The Ordinary and Extraordinary General Shareholders' Meeting of Spineway, convened on August 16, 2019 at 9H00 CET at the Company's registered office, has not reached the quorum required for its good performance and will be postponed to a later date in the coming weeks.


SPINEWAY IS ELIGIBLE FOR THE PEA-PME (EQUITY SAVINGS PLANS FOR SMES)

Find out all about Spineway at www.spineway.com

This press release has been prepared in both English and French. In case of discrepancies, the French version shall prevail.

Spineway designs, manufactures and markets innovative implants and surgical instruments for treating severe disorders of the spinal column.
Spineway has an international network of over 50 independent distributors and 90% of its revenue comes from exports.
Spineway, which is eligible for investment through FCPIs (French unit trusts specializing in innovation), has received the OSEO Excellence award since 2011 and has won the Deloitte Fast 50 award (2011). Rhône Alpes INPI Patent Innovation award (2013) – INPI Talent award (2015). ISIN: FR0011398874 - ALSPW       

Contacts:

Spineway

Shareholder-services line
Available Tuesday through Thursday
(10 a.m. – 12 p.m.)
+33 (0)811 045 555

 
 Aelium

Investor relations
Solène Kennis
spineway@aelium.fr

Attachment